Skip to main content Accessibility help
×
Home

Acquisition of Multidrug-Resistant Organisms Among Hospital Patients Hospitalized in Beds Adjacent to Critically Ill Patients

  • Matan J. Cohen (a1) (a2), Olga Anshelevich (a1) (a3), David Raveh (a1), Ellen Broide (a1) (a4), Bernard Rudensky (a4) and Amos M. Yinnon (a1) (a2)...

Abstract

Objective.

To assess whether patients hospitalized in beds physically adjacent to critically ill patients are at increased risk to acquire multidrug-resistant pathogens.

Design.

Cohort study.

Setting.

Shaare Zedek Medical Center, a 550-bed medical referral center.

Patients.

From April to September 2004, we enrolled consecutive newly admitted patients who were hospitalized in beds adjacent to either mechanically ventilated patients or patients designated as “do not resuscitate” (DNR). For each of these patients, we also enrolled a control patient who was not hospitalized in a bed adjacent to a critically ill patient. We collected specimens from the anterior nares, the oral cavity, and the perianal zone at the time of admission and subsequently at 3-day intervals until discharge or death. Specimens were cultured on selective media to detect growth of antibiotic-resistant pathogens, including Acinetobacter baumannii, methicillin-resistant Staphylococcus aureus (MRSA), extended-spectrum β lactamase (ESBL)–producing Enterobacteriaceae, and vancomycin-resistant enterococci (VRE).

Results.

We enrolled 46 neighbor-control pairs. Among neighbors and controls, respectively, the incidence rates for isolation of A. baumannii was 8.3 and 4 isolations per 100 patient-days (relative risk [RR], 2.1 [95% confidence interval {CI}, 0.8-5.2]; P = .12), the incidence rates for MRSA were 1.4 and 2.6 isolations per 100 patient-days (RR, 0.6 [95% CI, 0.1-2.3]; P = .45), the incidence rates for ESBL-producing Enterobacteriaceae were 10.5 and 9 isolations per 100 patient-days (RR, 1.2 [95% CI, 0.6-2.4]; P = .84), the incidence rates for VRE were 4.3 and 4.8 isolations per 100 patient-days (RR, 0.9 [95% CI, 0.3-2.4]; P = 1), and the composite incidence rate was 21.7 and 16.2 isolations per 100 patient-days (RR, 1.3 [95% CI, 0.8-2.3]; P = 0.3).

Conclusions.

In this pilot study, we did not detect an increased incidence rate of isolation of multidrug-resistant pathogens among patients hospitalized in beds adjacent to critically ill patients. Further studies with larger samples should be conducted in order to generate valid data and provide patients, physicians, and policy makers with a sufficient knowledge base from which decisions can be made.

Copyright

Corresponding author

Infectious Disease Unit, Shaare Zedek Medical Center, P.O. Box 3235, Jerusalem 91031, Israel (matan123@md.huji.ac.il)

References

Hide All
1.Grundmann, H, Bärwolff, S, Tami, A, et al. How many infections are caused by patient-to-patient transmission in intensive care units? Crit Care Med 2005; 33:946951.
2.Nijssen, S, Bonten, MJM, Weinstein, RA. Are active microbiological surveillance and subsequent isolation needed to prevent the spread of methicillin-resistant Staphylococcus aureus? Clin Infect Dis 2005; 40:405409.
3.National Committee for Clinical Laboratory Standards (NCCLS). Performance Standards for Antimicrobial Disk Susceptibility Testing. Informational supplement M100-S9. Wayne, PA; NCCLS; 2004.
4.Tenover, FC, Arbeit, RD, Goering, RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33:22332239.
5.Bradley, SF. Staphylococcus aureus infections and antibiotic resistance in older adults. Clin Infect Dis 2002; 34:211216.
6.Paterson, DL. Extended-spectrum beta-lactamases: the European experience. Curr Opin Infect Dis 2001; 14:697701.
7.Murray, BE. Vancomycin-resistant enterococcal infections. N Engl J Med 2000; 342:710718.
8.Cisneros, JM, Rodríguez-Bano, J. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect 2002; 8:687693.
9.Vincent, JL. Nosocomial infections in adult intensive-care units. Lancet 2003; 361:20682077.
10.Goossens, H, Ferech, M, Stichele, RV, Elseviers, M, for the ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365:579587.
11.Albrich, WC, Monnet, DL, Harbarth, S. Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg Infect Dis 2004; 10:1417.
12.Bergman, M, Huikko, S, Pihlajamaki, M, Palva, E, Huovinen, P, Seppala, H. Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997–2001. Clin Infect Dis 2004; 38:12511256.
13.Guillemot, D, Carbon, C, Balkau, B, et al. Low dosage and long treatment duration of beta-lactams: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA 1998; 279:365370.
14.Arason, VA, Kristinsson, KG, Sigurdsson, JA, Stefansdottir, G, Molstad, S, Gudmundsson, S. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross-sectional prevalence study. BMJ 1996; 313:387391.
15.Harbarth, S, Harris, AD, Carmeli, Y, Samore, MH. Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli. Clin Infect Dis 2001; 33:14621468.
16.Cepeda, JA, Whitehouse, T, Cooper, B, et al. Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two-centre study. Lancet 2005; 365:295304.
17.Stelfox, HT, Bates, DW, Redelmeier, DA. Safety of patients isolated for infection control. JAMA 2003; 290:18991905.
18.Cooper, BS, Stone, SP, Kibbler, CC, et al. Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modeling. Health Technol Assess 2003; 7:1194.
19.Cooper, BS, Stone, SP, Kibbler, SP, et al. Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature. BMJ 2004; 329:533540.

Acquisition of Multidrug-Resistant Organisms Among Hospital Patients Hospitalized in Beds Adjacent to Critically Ill Patients

  • Matan J. Cohen (a1) (a2), Olga Anshelevich (a1) (a3), David Raveh (a1), Ellen Broide (a1) (a4), Bernard Rudensky (a4) and Amos M. Yinnon (a1) (a2)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed